The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Hosted on MSN15d
PMGC highlights ‘strong’ capital positionPMGC (ELAB) Holdings highlighting its financial position and ongoing commitment to executing its strategic priorities through its operating subsidiaries. As of February 25, 2025, PMGC’s capital ...
06:24 EST PMGC (ELAB) files to sell 969,386 shares of common stock for holders Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make ...
(RTTNews) - Northstrive Biosciences, a subsidiary of PMGC Holdings Inc. (ELAB), on Tuesday announced the submission of a pre-investigational New Drug or pre-IND meeting request to the FDA for EL-22.
PMGC Holdings remains dedicated to innovative solutions and delivering long-term value for its shareholders. About PMGC Holdings Inc. PMGC Holdings Inc. is a diversified holding company that ...
NEWPORT BEACH, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the "Company” or "PMGC,” "our,” or "we”) (Nasdaq: ELAB), a diversified holding ...
PMGC Holdings Inc. NEWPORT BEACH, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-7 ...
As of February 25, 2025, PMGC’s capital structure is as follows: Common Shares Outstanding: 4,042,295. Stock Options Outstanding: 4,931 shares of Common Stock issuable upon the exercise of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback